Ireland - English - HPRA (Health Products Regulatory Authority)

santen oy - tafluprost; timolol maleate - eye drops, solution - 15/5 microgram(s)/millilitre - timolol, combinations

Malta - English - Medicines Authority

santen oy niittyhaankatu 20, 33720 tampere, finland - tafluprost, timolol maleate - eye drops, solution - tafluprost 15 µg/ml timolol maleate 5 mg/ml - ophthalmologicals

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

santen pharma malaysia sdn. bhd. - tafluprost; timolol maleate -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

santen oy - timolol maleate 6,84 mg/ml - eq. timolol 5 mg/ml; tafluprost 15 µg/ml - eye drops, solution - 15 µg/ml - 5 mg/ml - timolol maleate 6.84 mg/ml; tafluprost 15 µg/ml - timolol, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

santen uk ltd - timolol maleate; tafluprost - eye drops - 5mg/1ml ; 15microgram/1ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

santen pharma malaysia sdn. bhd. - timolol maleate; tafluprost -

Singapore - English - HSA (Health Sciences Authority)

santen pharmaceutical asia pte. ltd. - tafluprost; timolol maleate 6.84 mg/ml eqv timolol - solution, sterile - tafluprost 0.015 mg/ml; timolol maleate 6.84 mg/ml eqv timolol 5.00 mg/ml

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg - timolol maleate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. timolol is indicated in patients who have survived the acute phase of myocardial infarction, and are clinically stable, to reduce cardiovascular mortality and the risk of reinfarction. timolol is indicated for the prophylaxis of migraine headache. timolol maleate is contraindicated in patients with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; hypersensitivity to this product.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg - timolol maleate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. timolol is indicated in patients who have survived the acute phase of myocardial infarction, and are clinically stable, to reduce cardiovascular mortality and the risk of reinfarction. timolol is indicated for the prophylaxis of migraine headache. timolol maleate is contraindicated in patients with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; hypersensitivity to this product.

United States - English - NLM (National Library of Medicine)

akorn - timolol (unii: 817w3c6175) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 2.5 mg in 1 ml - timolol is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol is contraindicated in patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, or severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.